secwatch.observer — SEC 8-K summary
======================================

Issuer:     vTv Therapeutics Inc. (VTVT)
CIK:        0001641489
Form:       8-K
Filed at:   2024-03-05T23:59:59+00:00
Accession:  0001641489-24-000005
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

vTv Therapeutics posts updated investor slide presentation on March 5, 2024
---------------------------------------------------------------------------

- Company released updated slide presentation on its website for use in investor meetings.
- Presentation focuses on Type 1 Diabetes program and company overview.
- No specific financial results, guidance, or pipeline milestones disclosed in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1641489/000164148924000005/0001641489-24-000005-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1641489/000164148924000005/vtvt-20240305.htm
  HTML page:      https://secwatch.observer/filing/0001641489-24-000005

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer